Latest News About - Ophthalmic and optical devices

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Sunday, October 17, 2021

4:58:00 PM CEST

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ab
ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fo
fr
ga
gl
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
my
ne
nl
no
ny
os
pap
pl
ps
pt
ro
ru
se
si
sk
sl
so
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

Gary Bolton said: “We’re seeing the largest investment cycle in history for fiber infrastructure. 5G is going to significantly benefit from that because you can have all the latest radios in the world, but if you don’t have the 5G infrastructure, you’re not gonna get very far,” External link

thehill Thursday, October 14, 2021 12:06:00 PM CEST

Prof Dr said: “The positive longer-term efficacy and safety results for ENSPRYNG are important for physicians as they consider ENSPRYNG as a treatment option for their patients,” External link

4-traders Thursday, October 14, 2021 7:05:00 AM CEST

Levi Garraway said: “We are pleased that these longer-term data further reinforce the previously observed efficacy and safety of ENSPRYNG, which was specifically designed for this lifelong, chronic disease by targeting the IL-6 pathway to reduce the frequency of relapses,” External link

4-traders Thursday, October 14, 2021 7:05:00 AM CEST

Levi Garraway said: “Many neurologists have had first-hand experience with OCREVUS over eight years in clinical trials and witnessed the consistently favourable efficacy and safety outcomes in RMS and PPMS, especially the reductions in progression to disability when given early in the disease,” External link

4-traders Wednesday, October 13, 2021 7:02:00 AM CEST

Robert Kirsch said: “The Case-Coulter Translational Research Partnership continues to be a cornerstone of our department, filling an essential gap to transition university biomedical technologies from research to products, where they can significantly improve the health of our society,” External link

miragenews Tuesday, October 12, 2021 4:58:00 PM CEST

Most associated names

Daily number of articles in this category

Trend data not available for this selection.